-transparent.png){kind=logo}
A coagulant component has been purified from Cerastes cerastes venom, using gel filtration on a Sephadex G 100 (fine) column followed by chromatography on a Bio-Rex 70 column. This compound had a proteolytic effect and could coagulate human plasma deficient in factor VIII or (VIII + IX) with the formation of a firm clot. It could also clot plasma deficient in factor X, but the clot formed was soft and not complete. The compound had no effect on platelet aggregation and was nontoxic. This compound is believed to be primarily a factor X activator, as it could replace factor VIII in hemophilic plasmas.
Related Publications
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
January 1981,
Toxicon : official journal of the International Society on Toxinology,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
July 1995,
Biochimica et biophysica acta,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
February 1988,
Biochemical and biophysical research communications,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
March 1986,
Thrombosis research,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
April 1986,
Thrombosis research,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
January 1990,
Immunopharmacology,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
January 1988,
Toxicon : official journal of the International Society on Toxinology,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
January 1981,
Toxicon : official journal of the International Society on Toxinology,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
August 1993,
Toxicon : official journal of the International Society on Toxinology,
M F el-Asmar, and
E Shaban, and
M Hagag, and
N Swelam, and
A Tu
June 1993,
Toxicon : official journal of the International Society on Toxinology,
